Edition:
United States

Reata Pharmaceuticals Inc (RETA.OQ)

RETA.OQ on NASDAQ Stock Exchange Global Market

40.97USD
20 Jun 2018
Change (% chg)

$0.07 (+0.17%)
Prev Close
$40.90
Open
$40.97
Day's High
$40.97
Day's Low
$40.95
Volume
1,382
Avg. Vol
69,466
52-wk High
$41.43
52-wk Low
$19.32

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Mar '18 32.39 0.153
FY 2017 Dec '17 9.96 -0.638
Sep '17 12.56 -0.495
Jun '17 12.81 -0.518
Mar '17 12.73 -0.318
FY 2016 Dec '16 12.50 -0.185
Sep '16 12.55 -0.040
Jun '16 12.37 -0.050
Mar '16 12.44 -0.013
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-18 5 9.79 12.50 7.29 9.89
Quarter Ending Sep-18 5 10.04 12.50 7.29 9.89
Year Ending Dec-18 5 61.83 69.90 54.27 45.91
Year Ending Dec-19 5 44.82 59.31 28.27 52.05
Earnings (per share)
Quarter Ending Jun-18 6 -0.74 -0.57 -0.86 -0.41
Quarter Ending Sep-18 6 -0.70 -0.48 -0.86 -0.42
Year Ending Dec-18 6 -1.96 -1.40 -2.58 -1.68
Year Ending Dec-19 6 -2.94 -2.13 -3.82 -2.35
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 235.76 33.88
P/E High - Last 5 Yrs. -- 288.75 47.66
P/E Low - Last 5 Yrs. -- 99.96 25.18
Beta -- 0.73 0.78
Price to Sales (TTM) 14.78 260.48 8.30
Price to Book (MRQ) -- 23.31 4.32
Price to Tangible Book (MRQ) -- 30.41 5.99
Price to Cash Flow (TTM) -- 138.67 22.70
% Owned Institutions 66.76 11.74 2.41

Dividends

  Company industry sector
Dividend Yield -- 0.33 1.69
Dividend Yield - 5 Year Avg -- 0.20 1.42
Dividend 5 Year Growth Rate -- 2.20 -6.64
Payout Ratio(TTM) -- 41.81 40.53

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 154.41 24.25 5.00
Sales (TTM) vs TTM 1 Yr. Ago 35.03 136.30 12.65
Sales - 5 Yr. Growth Rate -- 30.91 7.92
EPS (MRQ) vs Qtr. 1 Yr. Ago 148.26 -78.19 40.28
EPS (TTM) vs TTM 1 Yr. Ago -142.81 -- --
EPS - 5 Yr. Growth Rate -- 48.46 8.01
Capital Spending - 5 Yr. Growth Rate -- 36.01 7.43

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.67 2.55
Current Ratio (MRQ) 2.62 6.32 3.64
LT Debt to Equity (MRQ) -- 22.16 12.89
Total Debt to Equity (MRQ) -- 26.56 17.35
Interest Coverage (TTM) -- -139.50 35.70

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.80 54.88
Gross Margin - 5 Yr. Avg. -- 55.31 52.82
EBITD Margin (TTM) -51.79 -- --
EBITD - 5 Yr. Avg -- -166.28 15.78
Operating Margin (TTM) -52.40 -923.67 -0.49
Operating Margin - 5 Yr. Avg. -- -179.82 11.04
Pre-Tax Margin (TTM) -53.88 -813.20 1.49
Pre-Tax Margin - 5 Yr. Avg. -- -183.43 11.21
Net Profit Margin (TTM) -53.89 -806.44 -1.80
Net Profit Margin - 5 Yr. Avg. -- -182.19 7.56
Effective Tax Rate (TTM) -- 15.36 29.88
Effective Tax Rate - 5 Yr. Avg. -- 19.24 24.11

Efficiency

  Company industry sector
Revenue/Employee (TTM) 728,151 21,567,119 743,658,643
Net Income/Employee (TTM) -392,376 -160,062 86,499,502
Receivable Turnover (TTM) -- 18.13 6.06
Inventory Turnover (TTM) -- 2.87 3.64
Asset Turnover (TTM) 0.60 0.48 0.88

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -32.44 -3.67 10.40
Return on Assets - 5 Yr. Avg. -- -0.80 11.13
Return on Investment (TTM) -59.61 -5.45 13.21
Return on Investment - 5 Yr. Avg. -- 2.04 14.44
Return on Equity (TTM) -- -6.94 15.18
Return on Equity - 5 Yr. Avg. -- -3.02 15.79
  1 Year 3 Year 5 Year
Sales % -3.61 -2.56 --
EPS (TTM) % -533.88 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Reata Pharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 67.57%
# of Holders: 137
Total Shares Held: 13,638,576
3 Mo. Net Change: 450,057
# New Positions: 16
# Closed Positions: 13
# Increased Positions: 57
# Reduced Positions: 44
# Net Buyers: 13
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.